Cargando…
Monomethyl Auristatin E Grafted-Liposomes to Target Prostate Tumor Cell Lines
Novel nanomedicines have been engineered to deliver molecules with therapeutic potentials, overcoming drawbacks such as poor solubility, toxicity or short half-life. Lipid-based carriers such as liposomes represent one of the most advanced classes of drug delivery systems. A Monomethyl Auristatin E...
Autores principales: | Abawi, Ariana, Wang, Xiaoyi, Bompard, Julien, Bérot, Anna, Andretto, Valentina, Gudimard, Leslie, Devillard, Chloé, Petiot, Emma, Joseph, Benoit, Lollo, Giovanna, Granjon, Thierry, Girard-Egrot, Agnès, Maniti, Ofelia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071391/ https://www.ncbi.nlm.nih.gov/pubmed/33921088 http://dx.doi.org/10.3390/ijms22084103 |
Ejemplares similares
-
Peripheral neuropathy associated with monomethyl auristatin E-based antibody-drug conjugates
por: Fu, Zhiwen, et al.
Publicado: (2023) -
Whole-Body Pharmacokinetics and Physiologically Based Pharmacokinetic Model for Monomethyl Auristatin E (MMAE)
por: Chang, Hsuan Ping, et al.
Publicado: (2021) -
Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy
por: Hingorani, Dina V., et al.
Publicado: (2022) -
Tumor-Specific Monomethyl Auristatin E (MMAE) Prodrug Nanoparticles for Safe and Effective Chemotherapy
por: Cho, Hanhee, et al.
Publicado: (2022) -
Activating Autophagy Enhanced the Antitumor Effect of Antibody Drug Conjugates Rituximab-Monomethyl Auristatin E
por: Wang, Yichen, et al.
Publicado: (2018)